ERBB2 and neoplasm: With miR-382 overexpression in the mammary gland, p53+/C;Erbb2 mice had shorter tumor-free survival than p53+/+;Erbb2 mice (Fig. 4g), in marked contrast to their untreated counterparts (Fig. 2f).